AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 DEC 13 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration has approved a solution that surgeons can use to help reduce postoperative surgical adhesions in women undergoing open gynecologic surgery. Adhesions (scars) are an undesirable clinical consequence of gynecologic surgery.
The product is Gynecare Intergel Adhesion Prevention Solution, manufactured by Lifecore Biomedical, Inc., of Chaska, Minnesota. FDA approved the solution based on a review of clinical studies of safety and effectiveness conducted by Lifecore.
A randomized trial inolving 281 women undergoing certain types of open gynecologic procedures at 16 medical centers in the United States and Europe compared the Intergel solution with standard irrigating solution.
The results showed that use of the Intergel solution was reasonably safe and was associated with a lower rate of adhesions than the standard treatment. Patients who received Intergel had approximately one less adhesion overall than those who received the standard solution, and there was a reduction in the number of women with moderate and ...